Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000117.xml
PiD - Psychotherapie im Dialog 2014; 15(02): 74-77
DOI: 10.1055/s-0034-1376937
DOI: 10.1055/s-0034-1376937
Aus der Praxis
Neurobiologie des Zwangs
Erkenntnisse und Bedeutung für die PsychotherapieFurther Information
Publication History
Publication Date:
18 June 2014 (online)
![](https://www.thieme-connect.de/media/pid/201402/lookinside/thumbnails/10.1055-s-0034-1376937-1.jpg)
Die neurobiologische Basis von Zwangsstörungen gilt mittlerweile als gut abgesichert, auch wenn noch nicht alle beteiligten Faktoren bekannt sind. Im Rahmen der Psychotherapie können neurobiologische Aspekte des Zwangs wertvoll sein, um Betroffenen die Entstehung und Aufrechterhaltung ihrer aufdringlichen Gedanken und belastenden Rituale zu vermitteln.
-
Literatur
- 1 Baxter LR, Schwartz JM, Bergmann KS et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 681-689
- 2 De Koning PP, Figee M, van den Munckhof P et al. Current status of deep Brain stimulation for obsessive-compulsive disorder: a clinical review of different targets. Curr Psychiatry Rep 2011; 13: 274-282
- 3 Figee M, Luigjes J, Smolders R et al. Deep brain stimulation restores fronto-striatal network activity in obsessive-compulsive disorder. Nat Neurosci 2013; 16: 386-387
- 4 Figee M, deKoning P, Klaassen S et al. Deep brain stimulation induces striatal dopamine release in obsessive-compulsive disorder. Biol Psychiatry 2014; 75: 647-652
- 5 Freyer T, Klöppel S, Tüscher O et al. Fronto-striatal activation in patients with obsessive-compulsive disorder before and after cognitive behavioral therapy. Psychol Med 2011; 41: 207-216
- 6 Van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet 2005; 8: 450-458
- 7 Jaafari N, de la Cruz LF, Grau M et al. Neurological soft signs in obsessive-compulsive disorder: two empirical studies and meta-analysis. Psychol Med 2013; 43: 1069-1079
- 8 Külz AK, Riemann D, Halsband U et al. Neuropsychological impairment in obsessive-compulsive disorder – improvement over the course of cognitive behavioral treatment. J Clin Exp Neuropsychol 2006; 28: 1273-1287
- 9 Külz AK, Meinzer S, Kopasz M, Voderholzer U. Effects of tryptophan depletion on cognitive functioning, obsessive-compulsive symptoms and mood in obsessive-compulsive disorder: preliminary results. Neuropsychobiol 2007; 56: 127-131
- 10 Külz AK, Rose N. Achtsamkeitsbasierte kognitive Therapie bei Zwangsstörungen: Eine Adaptation des Originalkonzepts. Psychother Psych Med 2014; 64: 35-40
- 11 Millet B, Dondaine T, Reymann JM et al. Obsessive compulsive disorder networks: positron emission tomography and neuropsychology provide new insights. PLoS One 2013; 8: e53241 DOI: 10.1371/journal. pone.0053241.
- 12 Moritz S, Kloss M, Jacobson D et al. Neurocognitive impairment does not predict treatment outcome in obsessive-compulsive disorder. Behav Res Ther 2005; 43: 811-819
- 13 O’Neill and Schwartz JM. The role of volition in OCD therapy: Neurocognitive, neuroimaging and neuroplastic aspects. Clin Neuropsychiatry 2004; 1: 13-31
- 14 Pauls DP. The genetics of obsessive-compulsive disorder: a review. Dialogues Clin Neurosci 2010; 12: 149-163
- 15 Sesia T, Bizup B, Grace AA. Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity. Int J Neuropsychopharmacol 2013; 16: 1295-1307
- 16 Shin NY, Lee TY, Kim E, Kwon JS. Cognitive functioning in obsessive-compulsive disorder: a meta-analysis. Psychol Med 2013; 149: 83-87
- 17 Snider L, Lougee L, Slattery M et al. Antibiotic prophylaxis with Azithromycinor Penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005; 57: 788-792
- 18 Voderholzer U, Schwartz C, Freyer T et al. Cognitive functioning in medication-free obsessive-compulsive patients treated with cognitive-behavioural therapy. J Obsess Compuls Rel Disord 2013; 2: 241-248
- 19 Welch JM, Lu J, Rodriguiz RM et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007; 448: 894-900
- 20 Wu K, Hanna GL, Rosenberg DR, Arnold PD. The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav 2012; 100: 726-735
- 21 Zurowski B, Kordon A, Weber-Fahr W et al. Relevance of orbitofrontal neurochemistry for the outcome of cognitive-behavioural therapy in patients with obsessive-compulsive disorder. Europ Arch Psychiatry Clin Neurosci 2012; 262: 617-624